-
A Spatial Interpolation Approach to Assign Magnetic Resonance Imaging-Derived Material Properties for Finite Element Models of Adeno-Associated Virus Infusion Into a Recurrent Brain Tumor. J Biomech Eng. 2024 Oct 01; 146(10).
Chen R, Rey JA, Tuna IS, Tran DD, Sarntinoranont M. PMID: 38581376; PMCID: PMC11110824.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors. J Neurooncol. 2023 Sep; 164(3):701-710.
Ernster AE, Body A, Deleyrolle P, St Clair J, Sampson D, Bacharz K, Yan SC, Melnick K, Allen A, Rahman M, Tran DD, Mitchell DA, Pereira DB, Ghiaseddin AP. PMID: 37804375; PMCID: PMC10695656.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases. Neurosurg Focus. 2023 08; 55(2):E9.
Cheok SK, Yu C, Feng JJ, Briggs RG, Chow F, Hwang L, Ye JC, Attenello FJ, Tran D, Chang E, Zada G. PMID: 37527673.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2023 01 01; 9(1):112-121.
Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudhary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML. PMID: 36394838; PMCID: PMC9673026.
View in:
PubMed Mentions:
95 Fields:
Translation:
HumansCellsPHPublic Health
-
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival. J Neurooncol. 2022 Sep; 159(2):479-484.
Melnick KF, Miller P, Carmichael E, McGrath K, Ghiaseddin A, Tran DD, Rahman M. PMID: 35840786.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Neurooncol Adv. 2022; 4(1):vdac042.
Butt OH, Zhou AY, Huang J, Leidig WA, Silberstein AE, Chheda MG, Johanns TM, Ansstas G, Liu J, Talcott G, Nakiwala R, Shimony JS, Kim AH, Leuthardt EC, Tran DD, Campian JL. PMID: 35505674; PMCID: PMC9054253.
View in:
PubMed Mentions:
1
-
Tumor Treating Fields: killing two birds with one stone. J Clin Invest. 2022 Apr 15; 132(8).
Lee J, Grabowski MM, Lathia JD. PMID: 35426370; PMCID: PMC9012279.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J Clin Invest. 2022 04 15; 132(8).
Chen D, Le SB, Hutchinson TE, Calinescu AA, Sebastian M, Jin D, Liu T, Ghiaseddin A, Rahman M, Tran DD. PMID: 35199647; PMCID: PMC9012294.
View in:
PubMed Mentions:
36 Fields:
Translation:
HumansAnimalsCells
-
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Neurooncol Adv. 2021; 3(1):vdab164.
Butt OH, Zhou AY, Huang J, Leidig WA, Silberstein AE, Chheda MG, Johanns TM, Ansstas G, Liu J, Talcott G, Nakiwala R, Shimony JS, Kim AH, Leuthardt EC, Tran DD, Campian JL. PMID: 34988450; PMCID: PMC8694207.
View in:
PubMed Mentions:
14
-
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic. Front Oncol. 2021; 11:679702.
Gatson NTN, Barnholtz-Sloan J, Drappatz J, Henriksson R, Hottinger AF, Hinoul P, Kruchko C, Puduvalli VK, Tran DD, Wong ET, Glas M. PMID: 34026655; PMCID: PMC8139188.
View in:
PubMed Mentions:
7
-
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Neuro Oncol. 2020 Oct 14; 22(10):1505-1515.
Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, Paleologos N, Fink K, Peereboom D, Chamberlain M, Merrell R, Penas Prado M, Yung WKA, Gilbert MR. PMID: 32166308; PMCID: PMC7686463.
View in:
PubMed Mentions:
19 Fields:
Translation:
HumansCTClinical Trials
-
In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas. J Neurooncol. 2021 Jan; 151(1):85-92.
Shin DH, Melnick KF, Tran DD, Ghiaseddin AP. PMID: 32757094.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansPHPublic Health
-
Tumor Treating Fields in the Management of Patients with Malignant Gliomas. Curr Treat Options Oncol. 2020 Jul 30; 21(9):76.
Ghiaseddin AP, Shin D, Melnick K, Tran DD. PMID: 32734509; PMCID: PMC7391234.
View in:
PubMed Mentions:
34 Fields:
Translation:
Humans
-
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial. Clin Cancer Res. 2020 04 01; 26(7):1586-1594.
Reardon DA, Desjardins A, Vredenburgh JJ, O'Rourke DM, Tran DD, Fink KL, Nabors LB, Li G, Bota DA, Lukas RV, Ashby LS, Duic JP, Mrugala MM, Cruickshank S, Vitale L, He Y, Green JA, Yellin MJ, Turner CD, Keler T, Davis TA, Sampson JH, ReACT trial investigators. PMID: 32034072.
View in:
PubMed Mentions:
68 Fields:
Translation:
Humans
-
Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity. PLoS One. 2019; 14(10):e0223555.
Jin D, Tran N, Thomas N, Tran DD. PMID: 31600301; PMCID: PMC6786609.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCells
-
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. Cancer. 2019 Nov 01; 125(21):3790-3800.
Galanis E, Anderson SK, Twohy EL, Carrero XW, Dixon JG, Tran DD, Jeyapalan SA, Anderson DM, Kaufmann TJ, Feathers RW, Giannini C, Buckner JC, Anastasiadis PZ, Schiff D. PMID: 31290996; PMCID: PMC6788934.
View in:
PubMed Mentions:
42 Fields:
Translation:
HumansCTClinical Trials
-
Quantitative characterization of 3D bioprinted structural elements under cell generated forces. Nat Commun. 2019 Jul 10; 10(1):3029.
Morley CD, Ellison ST, Bhattacharjee T, O'Bryan CS, Zhang Y, Smith KF, Kabb CP, Sebastian M, Moore GL, Schulze KD, Niemi S, Sawyer WG, Tran DD, Mitchell DA, Sumerlin BS, Flores CT, Angelini TE. PMID: 31292444; PMCID: PMC6620298.
View in:
PubMed Mentions:
26 Fields:
Translation:
AnimalsCells
-
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med. 2018 06 29; 16(1):179.
Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML. PMID: 29958537; PMCID: PMC6026340.
View in:
PubMed Mentions:
10 Fields:
-
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med. 2018 05 29; 16(1):142.
Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML. PMID: 29843811; PMCID: PMC5975654.
View in:
PubMed Mentions:
258 Fields:
Translation:
HumansCellsCTClinical Trials
-
Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma. Neuro Oncol. 2018 Mar 27; 20(4):472-483.
Mahlokozera T, Vellimana AK, Li T, Mao DD, Zohny ZS, Kim DH, Tran DD, Marcus DS, Fouke SJ, Campian JL, Dunn GP, Miller CA, Kim AH. PMID: 29244145; PMCID: PMC5909635.
View in:
PubMed Mentions:
24 Fields:
Translation:
Humans
-
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma. J Neurooncol. 2018 May; 138(1):105-111.
Huang J, Campian JL, Gujar AD, Tsien C, Ansstas G, Tran DD, DeWees TA, Lockhart AC, Kim AH. PMID: 29374809.
View in:
PubMed Mentions:
25 Fields:
Translation:
HumansCTClinical Trials
-
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA. 2017 Dec 19; 318(23):2306-2316.
Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z. PMID: 29260225; PMCID: PMC5820703.
View in:
PubMed Mentions:
1016 Fields:
Translation:
HumansCTClinical Trials
-
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply. Lancet Oncol. 2017 12; 18(12):e709-e710.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH. PMID: 29208433.
View in:
PubMed Mentions:
2 Fields:
-
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol. 2017 10; 18(10):1373-1385.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH, ACT IV trial investigators. PMID: 28844499.
View in:
PubMed Mentions:
503 Fields:
Translation:
HumansCTClinical Trials
-
An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci U S A. 2016 Dec 20; 113(51):E8247-E8256.
Gujar AD, Le S, Mao DD, Dadey DY, Turski A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, Rich KM, Milbrandt J, Hallahan DE, Yano H, Tran DD, Kim AH. PMID: 27930300; PMCID: PMC5187672.
View in:
PubMed Mentions:
60 Fields:
Translation:
HumansAnimalsCells
-
Molecular and histologic characteristics of pseudoprogression in diffuse gliomas. J Neurooncol. 2016 Dec; 130(3):529-533.
Lin AL, White M, Miller-Thomas MM, Fulton RS, Tsien CI, Rich KM, Schmidt RE, Tran DD, Dahiya S. PMID: 27704386; PMCID: PMC5518746.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansCells
-
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. J Neurooncol. 2016 Jun; 128(2):259-66.
Huang J, Campian JL, Gujar AD, Tran DD, Lockhart AC, DeWees TA, Tsien CI, Kim AH. PMID: 26966095.
View in:
PubMed Mentions:
37 Fields:
Translation:
HumansCTClinical Trials
-
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier. PLoS One. 2016; 11(2):e0148613.
Leuthardt EC, Duan C, Kim MJ, Campian JL, Kim AH, Miller-Thomas MM, Shimony JS, Tran DD. PMID: 26910903; PMCID: PMC4766093.
View in:
PubMed Mentions:
74 Fields:
Translation:
Humans
-
Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series. Case Rep Neurol. 2016; 8(1):1-9.
Ansstas G, Tran DD. PMID: 26889149; PMCID: PMC4748800.
View in:
PubMed Mentions:
10
-
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA. 2015 Dec 15; 314(23):2535-43.
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z. PMID: 26670971.
View in:
PubMed Mentions:
549 Fields:
Translation:
HumansCTClinical Trials
-
Central Nervous System Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Oct; 13(10):1191-202.
Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM. PMID: 26483059.
View in:
PubMed Mentions:
55 Fields:
Translation:
Humans
-
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors. Dis Markers. 2015; 2015:874904.
Vlassenko AG, McConathy J, Couture LE, Su Y, Massoumzadeh P, Leeds HS, Chicoine MR, Tran DD, Huang J, Dahiya S, Marcus DS, Fouke SJ, Rich KM, Raichle ME, Benzinger TL. PMID: 26424903; PMCID: PMC4573613.
View in:
PubMed Mentions:
20 Fields:
Translation:
HumansCells
-
A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells. Cell Rep. 2015 Jun 23; 11(11):1809-21.
Mao DD, Gujar AD, Mahlokozera T, Chen I, Pan Y, Luo J, Brost T, Thompson EA, Turski A, Leuthardt EC, Dunn GP, Chicoine MR, Rich KM, Dowling JL, Zipfel GJ, Dacey RG, Achilefu S, Tran DD, Yano H, Kim AH. PMID: 26074073; PMCID: PMC4481182.
View in:
PubMed Mentions:
50 Fields:
Translation:
HumansAnimalsCells
-
Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1000-1007.
Huang J, DeWees TA, Badiyan SN, Speirs CK, Mullen DF, Fergus S, Tran DD, Linette G, Campian JL, Chicoine MR, Kim AH, Dunn G, Simpson JR, Robinson CG. PMID: 26025775.
View in:
PubMed Mentions:
50 Fields:
Translation:
Humans
-
Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):268-76.
Speirs CK, Simpson JR, Robinson CG, DeWees TA, Tran DD, Linette G, Chicoine MR, Dacey RG, Rich KM, Dowling JL, Leuthardt EC, Zipfel GJ, Kim AH, Huang J. PMID: 25636755.
View in:
PubMed Mentions:
17 Fields:
Translation:
HumansCells
-
Stereotactic laser ablation of high-grade gliomas. Neurosurg Focus. 2014 Dec; 37(6):E1.
Hawasli AH, Kim AH, Dunn GP, Tran DD, Leuthardt EC. PMID: 25434378.
View in:
PubMed Mentions:
45 Fields:
Translation:
Humans
-
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Nov; 12(11):1517-23.
Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Moots PL, Mrugala MM, Newton HB, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK, Swinnen LJ, Tran D, Tran N, Vrionis FD, Wen PY, McMillian NR, Ho M. PMID: 25361798; PMCID: PMC4337873.
View in:
PubMed Mentions:
40 Fields:
Translation:
Humans
-
Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):877-85.
Badiyan SN, Markovina S, Simpson JR, Robinson CG, DeWees T, Tran DD, Linette G, Jalalizadeh R, Dacey R, Rich KM, Chicoine MR, Dowling JL, Leuthardt EC, Zipfel GJ, Kim AH, Huang J. PMID: 25257812.
View in:
PubMed Mentions:
25 Fields:
Translation:
Humans
-
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe). Semin Oncol. 2014 Oct; 41 Suppl 6:S4-S13.
Mrugala MM, Engelhard HH, Dinh Tran D, Kew Y, Cavaliere R, Villano JL, Annenelie Bota D, Rudnick J, Love Sumrall A, Zhu JJ, Butowski N. PMID: 25213869.
View in:
PubMed Mentions:
77 Fields:
Translation:
Humans
-
Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res. 2014 Nov 01; 74(21):6330-40.
Tran HD, Luitel K, Kim M, Zhang K, Longmore GD, Tran DD. PMID: 25164016; PMCID: PMC4925010.
View in:
PubMed Mentions:
122 Fields:
Translation:
HumansCells
-
Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma. Semin Oncol. 2014 Jun; 41 Suppl 4:S1-14.
Lacouture ME, Davis ME, Elzinga G, Butowski N, Tran D, Villano JL, DiMeglio L, Davies AM, Wong ET. PMID: 24794308.
View in:
PubMed Mentions:
49 Fields:
Translation:
Humans
-
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol. 2014 Jan; 16(1):123-30.
Lin AL, Liu J, Evans J, Leuthardt EC, Rich KM, Dacey RG, Dowling JL, Kim AH, Zipfel GJ, Grubb RL, Huang J, Robinson CG, Simpson JR, Linette GP, Chicoine MR, Tran DD. PMID: 24285548; PMCID: PMC3870829.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCells
-
Central nervous system cancers. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1114-51.
Nabors LB, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Maor MH, Moots PL, Morrison T, Mrugala MM, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK, Tran D, Tran N, Vrionis FD, Wen PY, McMillian N, Ho M, National Comprehensive Cancer Network. PMID: 24029126; PMCID: PMC4124889.
View in:
PubMed Mentions:
27 Fields:
Translation:
Humans
-
Antiangiogenic agents for nonmalignant brain tumors. J Neurol Surg B Skull Base. 2013 Jun; 74(3):136-41.
Hawasli AH, Rubin JB, Tran DD, Adkins DR, Waheed S, Hullar TE, Gutmann DH, Evans J, Leonard JR, Zipfel GJ, Chicoine MR. PMID: 24436903; PMCID: PMC3709924.
View in:
PubMed Mentions:
17
-
Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol Cancer Res. 2011 Dec; 9(12):1644-57.
Tran DD, Corsa CA, Biswas H, Aft RL, Longmore GD. PMID: 22006115; PMCID: PMC4922748.
View in:
PubMed Mentions:
97 Fields:
Translation:
HumansCells
-
CAML loss causes anaphase failure and chromosome missegregation. Cell Cycle. 2009 Mar 15; 8(6):940-9.
Liu Y, Malureanu L, Jeganathan KB, Tran DD, Lindquist LD, van Deursen JM, Bram RJ. PMID: 19229138; PMCID: PMC2967022.
View in:
PubMed Mentions:
13 Fields:
Translation:
AnimalsCells
-
Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA(A) receptors. Mol Cell Neurosci. 2008 Jun; 38(2):277-89.
Yuan X, Yao J, Norris D, Tran DD, Bram RJ, Chen G, Luscher B. PMID: 18424167; PMCID: PMC2350232.
View in:
PubMed Mentions:
25 Fields:
Translation:
HumansAnimalsCells
-
CAML is a p56Lck-interacting protein that is required for thymocyte development. Immunity. 2005 Aug; 23(2):139-52.
Tran DD, Edgar CE, Heckman KL, Sutor SL, Huntoon CJ, van Deursen J, McKean DL, Bram RJ. PMID: 16111633.
View in:
PubMed Mentions:
19 Fields:
Translation:
HumansAnimalsCells
-
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol. 2004 Sep; 24(18):8195-209.
Trushina E, Dyer RB, Badger JD, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT. PMID: 15340079; PMCID: PMC515048.
View in:
PubMed Mentions:
226 Fields:
Translation:
HumansAnimalsCells
-
CAML is required for efficient EGF receptor recycling. Dev Cell. 2003 Aug; 5(2):245-56.
Tran DD, Russell HR, Sutor SL, van Deursen J, Bram RJ. PMID: 12919676.
View in:
PubMed Mentions:
39 Fields:
Translation:
HumansAnimalsCells
-
Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem. 1997 May 09; 272(19):12650-61.
Horne MC, Donaldson KL, Goolsby GL, Tran D, Mulheisen M, Hell JW, Wahl AF. PMID: 9139721.
View in:
PubMed Mentions:
47 Fields:
Translation:
HumansAnimalsCells
-
Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem. 1996 Mar 15; 271(11):6050-61.
Horne MC, Goolsby GL, Donaldson KL, Tran D, Neubauer M, Wahl AF. PMID: 8626390.
View in:
PubMed Mentions:
53 Fields:
Translation:
HumansAnimalsCells